myTomorrows AI Trial Matching and Access Platform

myTomorrows is a health technology company that connects patients with treatments still in development, publishing from an Amsterdam address (Impatients N.V.). Its founder states it was started in 2012. It serves patients, physicians, advocacy groups and biopharma sponsors.

The platform uses AI to search registries such as ClinicalTrials.gov, EudraCT and ISRCTN and pre-screen patient profiles against eligibility criteria, with Patient Navigators supporting patients. For sponsors it offers patient recruitment, Expanded Access Program management and real-world data, and an expansion into Asia-Pacific began with an India hub in December 2024.

• AI trial matching: pre-screens patient profiles against eligibility criteria.
• Registry search: ClinicalTrials.gov, EudraCT and ISRCTN data in one search.
• Matching API (beta): embeds screening into EHR systems and internal tools.
• Patient Navigators: medical-background staff offering support in native languages.
• Sponsor services: patient recruitment, Expanded Access Program management and real-world data.
• Expanded access channel: physician requests for pre-approval access.

Vietnamese hospitals could use the Matching API to flag trial options for oncology or rare disease patients. Biopharma firms could use regional recruitment and expanded access support for Southeast Asian patients.

Returns trial matches within minutes (the company claims up to 90% less pre-screening time). Searches several global registries in one place. Connects to EHR systems. Adds multilingual Patient Navigators. Platform states ISO 27001, GDPR and HIPAA alignment.

Patients and physicians increasingly look for trials and pre-approval access beyond home markets, and AI matching lowers the effort. Asia-Pacific is a stated expansion area, and Vietnamese patients seeking novel therapies could be reached through regional navigators.

Amsterdam address (Impatients N.V.). EUR 25M growth investment from Avego Healthcare (undated on site). 2024-12: APAC expansion with India hub. Claims over 15,000 patients matched in 128 countries (2025-05).